Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chung Yin Kong, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Quantifying the gender difference in radiation risk from lung cancer screening and follow-up: A mathematical modeling study
Summer, 06/08/15 - 08/14/15

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Omidvari AH, Hazelton WD, Lauren BN, Naber SK, Lee M, Ali A, Seguin C, Kong CY, Richmond E, Rubenstein JH, Luebeck GE, Inadomi JM, Hur C, Lansdorp-Vogelaar I. The optimal age to stop endoscopic surveillance of Barrett's esophagus patients based on sex and comorbidity: a comparative cost-effectiveness analysis. Gastroenterology. 2021 May 08. PMID: 33974935.
    Citations:    Fields:    
  2. Hammer MM, Gupta S, Kong CY. Cost-Effectiveness of Management Algorithms for Lung-RADS Category 4 Nodules. Radiol Cardiothorac Imaging. 2021 Apr; 3(2):e200523. PMID: 33969309.
    Citations:    
  3. Sigel K, Kong CY, Rehmani S, Bates S, Gould M, Stone K, Kale M, Park YH, Crothers K, Bhora F, Wisnivesky J. Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities. PLoS One. 2021; 16(3):e0248067. PMID: 33735217.
    Citations:    Fields:    
  4. Meza R, Jeon J, Toumazis I, Ten Haaf K, Cao P, Bastani M, Han SS, Blom EF, Jonas DE, Feuer EJ, Plevritis SK, de Koning HJ, Kong CY. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. JAMA. 2021 03 09; 325(10):988-997. PMID: 33687469.
    Citations:    Fields:    Translation:Humans
  5. Cadham CJ, Cao P, Jayasekera J, Taylor KL, Levy DT, Jeon J, Elkin E, Foley KL, Joseph A, Kong CY, Minnix JA, Rigotti NA, Toll BA, Zeliadt SB, Meza R, Mandelblatt J. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study. J Natl Cancer Inst. 2021 Jan 23. PMID: 33484569.
    Citations:    Fields:    
  6. Watson TR, Gao X, Reynolds KL, Kong CY. Cost-effectiveness of Pembrolizumab Plus Axitinib Vs Nivolumab Plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the US. JAMA Netw Open. 2020 10 01; 3(10):e2016144. PMID: 33052401.
    Citations:    Fields:    Translation:Humans
  7. Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R. Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. PLoS Med. 2020 Sep; 17(9):e1003403. PMID: 32976487.
    Citations:    Fields:    
  8. Huang HL, Leung CY, Saito E, Katanoda K, Hur C, Kong CY, Nomura S, Shibuya K. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. BMC Med. 2020 09 14; 18(1):257. PMID: 32921305.
    Citations:    Fields:    Translation:HumansPHPublic Health
  9. Hammer MM, Byrne SC, Kong CY. Factors Influencing the False Positive Rate in CT Lung Cancer Screening. Acad Radiol. 2020 Sep 03. PMID: 32893112.
    Citations:    Fields:    
  10. Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020 08 13; 383(7):640-649. PMID: 32786189.
    Citations: 35     Fields:    Translation:Humans
  11. Gupta S, Jacobson FL, Kong CY, Hammer MM. Performance of Lung Nodule Management Algorithms for Lung-RADS Category 4 Lesions. Acad Radiol. 2020 Jun 12. PMID: 32540198.
    Citations: 1     Fields:    
  12. Criss SD, de Koning HJ, Plevritis SK, Meza R, Kong CY. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States. Ann Intern Med. 2020 05 19; 172(10):706-707. PMID: 32422089.
    Citations:    Fields:    Translation:HumansPHPublic Health
  13. Ten Haaf K, Bastani M, Cao P, Jeon J, Toumazis I, Han SS, Plevritis SK, Blom EF, Kong CY, Tammemägi MC, Feuer EJ, Meza R, de Koning HJ. A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies. J Natl Cancer Inst. 2020 05 01; 112(5):466-479. PMID: 31566216.
    Citations: 9     Fields:    Translation:Humans
  14. Tramontano AC, Chen Y, Watson TR, Eckel A, Hur C, Kong CY. Racial/ethnic disparities in colorectal cancer treatment utilization and phase-specific costs, 2000-2014. PLoS One. 2020; 15(4):e0231599. PMID: 32287320.
    Citations: 1     Fields:    Translation:Humans
  15. Hammer MM, Palazzo LL, Paquette A, Eckel AL, Jacobson FL, Barbosa EM, Kong CY. Cost-Effectiveness of Follow-Up for Subsolid Pulmonary Nodules in High-Risk Patients. J Thorac Oncol. 2020 08; 15(8):1298-1305. PMID: 32171847.
    Citations: 1     Fields:    Translation:Humans
  16. Criss SD, Palazzo L, Watson TR, Paquette AM, Sigel K, Wisnivesky J, Kong CY. Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden. PLoS One. 2020; 15(1):e0228288. PMID: 31995619.
    Citations:    Fields:    Translation:Humans
  17. Omidvari AH, Ali A, Hazelton WD, Kroep S, Lee M, Naber SK, Lauren BN, Ostvar S, Richmond E, Kong CY, Rubenstein JH, Lansdorp-Vogelaar I, Luebeck G, Hur C, Inadomi J. Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling. Clin Gastroenterol Hepatol. 2020 08; 18(9):1961-1969. PMID: 31816445.
    Citations: 1     Fields:    
  18. Tramontano AC, Chen Y, Watson TR, Eckel A, Sheehan DF, Peters MLB, Pandharipande PV, Hur C, Kong CY. Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000-2013. Medicine (Baltimore). 2019 Dec; 98(49):e18082. PMID: 31804317.
    Citations: 1     Fields:    Translation:Humans
  19. Criss SD, Cao P, Bastani M, Ten Haaf K, Chen Y, Sheehan DF, Blom EF, Toumazis I, Jeon J, de Koning HJ, Plevritis SK, Meza R, Kong CY. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study. Ann Intern Med. 2019 12 03; 171(11):796-804. PMID: 31683314.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  20. Hammer MM, Palazzo LL, Kong CY, Hunsaker AR. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial. Radiology. 2019 11; 293(2):441-448. PMID: 31526256.
    Citations: 9     Fields:    Translation:Humans
  21. Chen Y, Criss SD, Watson TR, Eckel A, Palazzo L, Tramontano AC, Wang Y, Mercaldo ND, Kong CY. Cost and Utilization of Lung Cancer End-of-Life Care Among Racial-Ethnic Minority Groups in the United States. Oncologist. 2020 01; 25(1):e120-e129. PMID: 31501272.
    Citations: 1     Fields:    Translation:Humans
  22. Criss SD, Mooradian MJ, Watson TR, Gainor JF, Reynolds KL, Kong CY. Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer in the United States. JAMA Netw Open. 2019 09 04; 2(9):e1911952. PMID: 31553470.
    Citations: 9     Fields:    Translation:Humans
  23. Chen Y, Watson TR, Criss SD, Eckel A, Palazzo L, Sheehan DF, Kong CY. A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea. PLoS One. 2019; 14(7):e0220610. PMID: 31361789.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  24. Tramontano AC, Chen Y, Watson TR, Eckel A, Hur C, Kong CY. Esophageal cancer treatment costs by phase of care and treatment modality, 2000-2013. Cancer Med. 2019 09; 8(11):5158-5172. PMID: 31347306.
    Citations: 3     Fields:    Translation:Humans
  25. Criss SD, Mooradian MJ, Kong CY. Changes to Model Assumptions of the Cost-effectiveness of Durvalumab Therapy for Non-Small Cell Lung Cancer-In Reply. JAMA Oncol. 2019 07 01; 5(7):1066-1067. PMID: 31095247.
    Citations:    Fields:    Translation:Humans
  26. Sigel KM, Stone K, Wisnivesky JP, Park LS, Kong CY, Silverberg MJ, Brown S, Goetz M, Rodriguez-Barradas MC, Gibert C, Shebl F, Bedimo R, Wadia R, King J, Crothers K. Short-term outcomes for lung cancer resection surgery in HIV infection. AIDS. 2019 07 01; 33(8):1353-1360. PMID: 30889013.
    Citations: 2     Fields:    Translation:Humans
  27. Rose J, Homa L, Kong CY, Cooper GS, Kattan MW, Ermlich BO, Meyers JP, Primrose JN, Pugh SA, Shinkins B, Kim U, Meropol NJ. Development and validation of a model to predict outcomes of colon cancer surveillance. Cancer Causes Control. 2019 Jul; 30(7):767-778. PMID: 31129907.
    Citations:    Fields:    Translation:Humans
  28. Yamamoto KN, Nakamura A, Liu LL, Stein S, Tramontano AC, Kartoun U, Shimizu T, Inoue Y, Asakuma M, Haeno H, Kong CY, Uchiyama K, Gonen M, Hur C, Michor F. Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. PLoS One. 2019; 14(4):e0215409. PMID: 31026288.
    Citations: 3     Fields:    Translation:Humans
  29. Tammemägi MC, Ten Haaf K, Toumazis I, Kong CY, Han SS, Jeon J, Commins J, Riley T, Meza R. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial. JAMA Netw Open. 2019 03 01; 2(3):e190204. PMID: 30821827.
    Citations: 5     Fields:    Translation:Humans
  30. Criss SD, Mooradian MJ, Sheehan DF, Zubiri L, Lumish MA, Gainor JF, Reynolds KL, Kong CY. Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System. JAMA Oncol. 2019 03 01; 5(3):358-365. PMID: 30543349.
    Citations: 6     Fields:    Translation:Humans
  31. Palazzo LL, Sheehan DF, Tramontano AC, Kong CY. Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients. Cancer Epidemiol Biomarkers Prev. 2019 05; 28(5):926-934. PMID: 30787053.
    Citations: 2     Fields:    Translation:Humans
  32. Yong PC, Sigel K, de-Torres JP, Mhango G, Kale M, Kong CY, Zulueta JJ, Wilson D, Brown SW, Slatore C, Wisnivesky J. The effect of radiographic emphysema in assessing lung cancer risk. Thorax. 2019 09; 74(9):858-864. PMID: 30723183.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  33. Weaver DT, Lietz AP, Mercaldo SF, Peters MLB, Hur C, Kong CY, Wolpin BM, Megibow AJ, Berland LL, Knudsen AB, Pandharipande PV. Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach. AJR Am J Roentgenol. 2019 03; 212(3):596-601. PMID: 30620679.
    Citations: 2     Fields:    Translation:Humans
  34. Sheehan DF, Criss SD, Chen Y, Eckel A, Palazzo L, Tramontano AC, Hur C, Cipriano LE, Kong CY. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare. Cancer Med. 2019 01; 8(1):94-103. PMID: 30575329.
    Citations: 13     Fields:    Translation:Humans
  35. Choi JG, Nipp RD, Tramontano A, Ali A, Zhan T, Pandharipande P, Dowling EC, Ferrone CR, Hong TS, Schrag D, Fernandez-Del Castillo C, Ryan DP, Kong CY, Hur C. Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. Oncologist. 2019 07; 24(7):945-954. PMID: 30559125.
    Citations: 3     Fields:    Translation:Humans
  36. Criss SD, Weaver DT, Sheehan DF, Lee RJ, Pandharipande PV, Kong CY. Effect of PD-L1 testing on the cost-effectiveness and budget impact of pembrolizumab for advanced urothelial carcinoma of the bladder in the United States. Urol Oncol. 2019 03; 37(3):180.e11-180.e18. PMID: 30528699.
    Citations: 1     Fields:    Translation:Humans
  37. Hammer MM, Palazzo LL, Eckel AL, Barbosa EM, Kong CY. A Decision Analysis of Follow-up and Treatment Algorithms for Nonsolid Pulmonary Nodules. Radiology. 2019 02; 290(2):506-513. PMID: 30457486.
    Citations: 5     Fields:    Translation:Humans
  38. Nipp RD, Tramontano AC, Kong CY, Hur C. Patterns and predictors of end-of-life care in older patients with pancreatic cancer. Cancer Med. 2018 12; 7(12):6401-6410. PMID: 30426697.
    Citations: 4     Fields:    Translation:Humans
  39. Jeon J, Holford TR, Levy DT, Feuer EJ, Cao P, Tam J, Clarke L, Clarke J, Kong CY, Meza R. Smoking and Lung Cancer Mortality in the United States From 2015 to 2065: A Comparative Modeling Approach. Ann Intern Med. 2018 11 20; 169(10):684-693. PMID: 30304504.
    Citations: 21     Fields:    Translation:Humans
  40. Tramontano AC, Nipp R, Mercaldo ND, Kong CY, Schrag D, Hur C. Survival Disparities by Race and Ethnicity in Early Esophageal Cancer. Dig Dis Sci. 2018 11; 63(11):2880-2888. PMID: 30109578.
    Citations: 6     Fields:    Translation:Humans
  41. Peters MLB, Eckel A, Mueller PP, Tramontano AC, Weaver DT, Lietz A, Hur C, Kong CY, Pandharipande PV. Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model. Pancreatology. 2018 Dec; 18(8):928-934. PMID: 30143405.
    Citations: 5     Fields:    Translation:Humans
  42. Tramontano AC, Nipp R, Kong CY, Yerramilli D, Gainor JF, Hur C. Hospice use and end-of-life care among older patients with esophageal cancer. Health Sci Rep. 2018 Sep; 1(9):e76. PMID: 30623099.
    Citations: 4     
  43. Eschenfeldt PC, Kartoun U, Heberle CR, Kong CY, Nishioka NS, Ng K, Kamarthi S, Hur C. Analysis of factors associated with extended recovery time after colonoscopy. PLoS One. 2018; 13(6):e0199246. PMID: 29927978.
    Citations: 3     Fields:    Translation:Humans
  44. Kong CY, Sigel K, Criss SD, Sheehan DF, Triplette M, Silverberg MJ, Henschke CI, Justice A, Braithwaite RS, Wisnivesky J, Crothers K. Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/µl. AIDS. 2018 06 19; 32(10):1333-1342. PMID: 29683843.
    Citations: 5     Fields:    Translation:Humans
  45. Criss SD, Sheehan DF, Palazzo L, Kong CY. Population impact of lung cancer screening in the United States: Projections from a microsimulation model. PLoS Med. 2018 02; 15(2):e1002506. PMID: 29415013.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  46. Nipp R, Tramontano AC, Kong CY, Pandharipande P, Dowling EC, Schrag D, Hur C. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018 02; 7(2):525-535. PMID: 29322643.
    Citations: 22     Fields:    Translation:Humans
  47. Chu JN, Choi J, Tramontano A, Morse C, Forcione D, Nishioka NS, Abrams JA, Rubenstein JH, Kong CY, Inadomi JM, Hur C. Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis. Clin Gastroenterol Hepatol. 2018 03; 16(3):392-400.e7. PMID: 29079222.
    Citations: 3     Fields:    Translation:Humans
  48. Reddy KP, Kong CY, Hyle EP, Baggett TP, Huang M, Parker RA, Paltiel AD, Losina E, Weinstein MC, Freedberg KA, Walensky RP. Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States. JAMA Intern Med. 2017 11 01; 177(11):1613-1621. PMID: 28975270.
    Citations: 22     Fields:    Translation:Humans
  49. Triplette M, Sigel KM, Morris A, Shahrir S, Wisnivesky JP, Kong CY, Diaz PT, Petraglia A, Crothers K. Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: implications for lung cancer screening. AIDS. 2017 07 31; 31(12):1715-1720. PMID: 28463881.
    Citations:    Fields:    Translation:Humans
  50. Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer. 2017 06 01; 140(11):2436-2443. PMID: 28073150.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  51. Lubitz C, Ali A, Zhan T, Heberle C, White C, Ito Y, Miyauchi A, Gazelle GS, Kong CY, Hur C. The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population. PLoS One. 2017; 12(5):e0177068. PMID: 28481909.
    Citations: 2     Fields:    Translation:Humans
  52. Tramontano AC, Sheehan DF, Yeh JM, Kong CY, Dowling EC, Rubenstein JH, Abrams JA, Inadomi JM, Schrag D, Hur C. The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. Am J Gastroenterol. 2017 Aug; 112(8):1256-1264. PMID: 28374815.
    Citations: 18     Fields:    Translation:Humans
  53. Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. PLoS Med. 2017 Apr; 14(4):e1002277. PMID: 28376113.
    Citations: 50     Fields:    Translation:HumansPHPublic Health
  54. Sheehan DF, Criss SD, Gazelle GS, Pandharipande PV, Kong CY. Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach. PLoS One. 2017; 12(3):e0173119. PMID: 28273181.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  55. Heberle CR, Omidvari AH, Ali A, Kroep S, Kong CY, Inadomi JM, Rubenstein JH, Tramontano AC, Dowling EC, Hazelton WD, Luebeck EG, Lansdorp-Vogelaar I, Hur C. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device. Clin Gastroenterol Hepatol. 2017 Sep; 15(9):1397-1404.e7. PMID: 28238953.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  56. Kroep S, Heberle CR, Curtius K, Kong CY, Lansdorp-Vogelaar I, Ali A, Wolf WA, Shaheen NJ, Spechler SJ, Rubenstein JH, Nishioka NS, Meltzer SJ, Hazelton WD, van Ballegooijen M, Tramontano AC, Gazelle GS, Luebeck EG, Inadomi JM, Hur C. Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis. Clin Gastroenterol Hepatol. 2017 09; 15(9):1471-1474. PMID: 28089850.
    Citations: 5     Fields:    Translation:Humans
  57. Hur C, Tramontano AC, Dowling EC, Brooks GA, Jeon A, Brugge WR, Gazelle GS, Kong CY, Pandharipande PV. Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening. Pancreas. 2016 08; 45(7):1062-6. PMID: 26692444.
    Citations: 7     Fields:    Translation:Humans
  58. Kong CY, Sheehan DF, McMahon PM, Gazelle GS, Pandharipande P. Combined Biomarker and Computed Tomography Screening Strategies for Lung Cancer: Projections of Health and Economic Tradeoffs in the US Population. MDM Policy Pract. 2016 Jul-Dec; 1(1). PMID: 30148212.
    Citations: 2     
  59. Tramontano AC, Sheehan DF, McMahon PM, Dowling EC, Holford TR, Ryczak K, Lesko SM, Levy DT, Kong CY. Evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the USA: a simulation modelling study. BMJ Open. 2016 Feb 29; 6(2):e010227. PMID: 26928026.
    Citations: 9     Fields:    Translation:Humans
  60. Pandharipande PV, Heberle C, Dowling EC, Kong CY, Tramontano A, Perzan KE, Brugge W, Hur C. Targeted Screening of Individuals at High Risk for Pancreatic Cancer: Results of a Simulation Model. Radiology. 2016 Jan; 278(1):306. PMID: 26691000.
    Citations: 1     Fields:    
  61. Pandharipande PV, Jeon A, Heberle CR, Dowling EC, Kong CY, Chung DC, Brugge WR, Hur C. Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model. EBioMedicine. 2015 Dec; 2(12):1980-6. PMID: 26844277.
    Citations: 3     Fields:    Translation:Humans
  62. Lowry KP, Turan EA, Eisenberg J, Kong CY, Barnes JA, Pandharipande PV. Projected Effects of Radiation-Induced Cancers on Life Expectancy in Patients Undergoing CT Surveillance for Limited-Stage Hodgkin Lymphoma: A Markov Model. AJR Am J Roentgenol. 2015 Jun; 204(6):1228-33. PMID: 26001232.
    Citations:    Fields:    Translation:HumansPHPublic Health
  63. Hur C, Choi SE, Kong CY, Wang GQ, Xu H, Polydorides AD, Xue LY, Perzan KE, Tramontano AC, Richards-Kortum RR, Anandasabapathy S. High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis. World J Gastroenterol. 2015 May 14; 21(18):5513-23. PMID: 25987774.
    Citations: 3     Fields:    Translation:Humans
  64. Lowry KP, Gazelle GS, Gilmore ME, Johanson C, Munshi V, Choi SE, Tramontano AC, Kong CY, McMahon PM. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis. Cancer. 2015 May 15; 121(10):1556-62. PMID: 25652107.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  65. Kang SK, Turan EA, Eisenberg JD, Lee PA, Kong CY, Pandharipande PV. Microsimulation model of CT versus MRI surveillance of Bosniak IIF renal cystic lesions: should effects of radiation exposure affect selection of imaging strategy? AJR Am J Roentgenol. 2014 Dec; 203(6):W629-36. PMID: 25415728.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  66. Pandharipande PV, Heberle C, Dowling EC, Kong CY, Tramontano A, Perzan KE, Brugge W, Hur C. Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model. Radiology. 2015 Apr; 275(1):177-87. PMID: 25393849.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  67. Swan JS, Kong CY, Hur C, Halpern EF, Itauma O, Williams O, Motazedi T, Lee JM. Comparing morbidities of testing with a new index: screening colonoscopy versus core-needle breast biopsy. J Am Coll Radiol. 2015 Mar; 12(3):295-301. PMID: 25441485.
    Citations:    Fields:    Translation:Humans
  68. Kong CY, Meng L, Omer ZB, Swan JS, Srouji S, Gazelle GS, Fennessy FM. MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis. AJR Am J Roentgenol. 2014 Aug; 203(2):361-71. PMID: 25055272.
    Citations: 12     Fields:    Translation:Humans
  69. Kiatpongsan S, Meng L, Eisenberg JD, Herring M, Avery LL, Kong CY, Pandharipande PV. Imaging for appendicitis: should radiation-induced cancer risks affect modality selection? Radiology. 2014 Nov; 273(2):472-82. PMID: 24988435.
    Citations: 1     Fields:    Translation:Humans
  70. McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ. Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. PLoS One. 2014; 9(6):e99978. PMID: 24979231.
    Citations: 15     Fields:    Translation:Humans
  71. Enns EA, Cipriano LE, Simons CT, Kong CY. Identifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach. Med Decis Making. 2015 02; 35(2):170-82. PMID: 24799456.
    Citations: 6     Fields:    Translation:Humans
  72. Eisenberg JD, Gilmore ME, Kalra MK, Kong CY, Pandharipande PV. Prioritizing examination-centered over patient-centered dose reduction: a hazard of institutional "benchmarking". AJR Am J Roentgenol. 2014 May; 202(5):1062-8. PMID: 24758661.
    Citations:    Fields:    Translation:Humans
  73. Rose J, Augestad KM, Kong CY, Meropol NJ, Kattan MW, Hong Q, An X, Cooper GS. A simulation model of colorectal cancer surveillance and recurrence. BMC Med Inform Decis Mak. 2014 Apr 08; 14:29. PMID: 24708517.
    Citations: 3     Fields:    Translation:Humans
  74. Kong CY, Kroep S, Curtius K, Hazelton WD, Jeon J, Meza R, Heberle CR, Miller MC, Choi SE, Lansdorp-Vogelaar I, van Ballegooijen M, Feuer EJ, Inadomi JM, Hur C, Luebeck EG. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol Biomarkers Prev. 2014 Jun; 23(6):997-1006. PMID: 24692500.
    Citations: 27     Fields:    Translation:Humans
  75. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammemägi MC, Hazelton WD, Feuer EJ, McMahon PM. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014 Mar 04; 160(5):311-20. PMID: 24379002.
    Citations: 143     Fields:    Translation:HumansPHPublic Health
  76. Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. Cancer. 2014 Jun 01; 120(11):1713-24. PMID: 24577803.
    Citations: 31     Fields:    Translation:Humans
  77. Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, Gazelle GS, Weinstein MC. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer. 2014 May 01; 120(9):1345-52. PMID: 24481684.
    Citations: 42     Fields:    Translation:Humans
  78. Choi SE, Perzan KE, Tramontano AC, Kong CY, Hur C. Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis. Cancer Prev Res (Phila). 2014 Mar; 7(3):341-50. PMID: 24380852.
    Citations: 7     Fields:    Translation:Humans
  79. Humphrey KL, Lee JM, Donelan K, Kong CY, Williams O, Itauma O, Halpern EF, Gerade BJ, Rafferty EA, Swan JS. Percutaneous breast biopsy: effect on short-term quality of life. Radiology. 2014 Feb; 270(2):362-8. PMID: 24471385.
    Citations: 3     Fields:    Translation:Humans
  80. Pandharipande PV, Eisenberg JD, Avery LL, Gunn ML, Kang SK, Megibow AJ, Turan EA, Harvey HB, Kong CY, Dowling EC, Halpern EF, Donelan K, Gazelle GS. Journal club: How radiation exposure histories influence physician imaging decisions: a multicenter radiologist survey study. AJR Am J Roentgenol. 2013 Jun; 200(6):1275-83. PMID: 23701064.
    Citations: 8     Fields:    Translation:Humans
  81. Swan JS, Kong CY, Lee JM, Itauma O, Halpern EF, Lee PA, Vavinskiy S, Williams O, Zoltick ES, Donelan K. Patient and societal value functions for the testing morbidities index. Med Decis Making. 2013 08; 33(6):819-38. PMID: 23689044.
    Citations: 5     Fields:    Translation:Humans
  82. Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer. AJR Am J Roentgenol. 2013 May; 200(5):1020-7. PMID: 23617484.
    Citations: 2     Fields:    Translation:Humans
  83. Pandharipande PV, Eisenberg JD, Lee RJ, Gilmore ME, Turan EA, Singh S, Kalra MK, Liu B, Kong CY, Gazelle GS. Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox. Radiology. 2013 Mar; 266(3):896-904. PMID: 23249573.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  84. Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013 Mar 15; 119(6):1149-58. PMID: 23303625.
    Citations: 154     Fields:    Translation:Humans
  85. Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS. Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer. 2013 Mar 15; 119(6):1266-76. PMID: 23184400.
    Citations: 17     Fields:    Translation:Humans
  86. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS. Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal. 2012 Jul; 32 Suppl 1:S117-24. PMID: 22882882.
    Citations: 17     Fields:    Translation:Humans
  87. Hur C, Choi SE, Rubenstein JH, Kong CY, Nishioka NS, Provenzale DT, Inadomi JM. The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology. 2012 Sep; 143(3):567-575. PMID: 22626608.
    Citations: 43     Fields:    Translation:Humans
  88. Omer ZB, Ananthakrishnan AN, Nattinger KJ, Cole EB, Lin JJ, Kong CY, Hur C. Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):722-7. PMID: 22426086.
    Citations: 27     Fields:    Translation:Humans
  89. Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F, McCarthy W, Boer R, Gorlova O, Gazelle GS, Kimmel M, McMahon PM, de Koning HJ, Feuer EJ. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst. 2012 Apr 04; 104(7):541-8. PMID: 22423009.
    Citations: 58     Fields:    Translation:Humans
  90. Kong CY, Lee JM, McMahon PM, Lowry KP, Omer ZB, Eisenberg JD, Pandharipande PV, Gazelle GS. Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections. Radiology. 2012 Mar; 262(3):977-84. PMID: 22357897.
    Citations: 5     Fields:    Translation:Humans
  91. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011 Nov; 6(11):1841-8. PMID: 21892105.
    Citations: 69     Fields:    Translation:HumansPHPublic Health
  92. Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer. 2012 Apr 15; 118(8):2021-30. PMID: 21935911.
    Citations: 20     Fields:    Translation:Humans
  93. Kong CY, Nattinger KJ, Hayeck TJ, Omer ZB, Wang YC, Spechler SJ, McMahon PM, Gazelle GS, Hur C. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev. 2011 Nov; 20(11):2450-6. PMID: 21930957.
    Citations: 18     Fields:    Translation:Humans
  94. Fennessy FM, Kong CY, Tempany CM, Swan JS. Quality-of-life assessment of fibroid treatment options and outcomes. Radiology. 2011 Jun; 259(3):785-92. PMID: 21364084.
    Citations: 12     Fields:    Translation:Humans
  95. Swan JS, Ying J, Stahl J, Kong CY, Moy B, Roy J, Halpern E. Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing. Qual Life Res. 2010 Apr; 19(3):401-12. PMID: 20084464.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  96. Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010 Aug; 23(6):451-7. PMID: 20353441.
    Citations: 53     Fields:    Translation:Humans
  97. Hur C, Hayeck TJ, Yeh JM, Richards EM, Richards EB, Spechler SJ, Gazelle GS, Kong CY. Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One. 2010 Mar 01; 5(3):e9483. PMID: 20208996.
    Citations: 7     Fields:    Translation:Humans
  98. Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology. 2010 Mar; 254(3):793-800. PMID: 20177093.
    Citations: 20     Fields:    Translation:HumansPHPublic Health
  99. Prosser LA, Kong CY, Rusinak D, Waisbren SL. Projected costs, risks, and benefits of expanded newborn screening for MCADD. Pediatrics. 2010 Feb; 125(2):e286-94. PMID: 20123779.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  100. Aminetzach YT, Srouji JR, Kong CY, Hoekstra HE. Convergent evolution of novel protein function in shrew and lizard venom. Curr Biol. 2009 Dec 01; 19(22):1925-31. PMID: 19879144.
    Citations: 18     Fields:    Translation:AnimalsCells
  101. Cheng Z, Saito K, Pisarev AV, Wada M, Pisareva VP, Pestova TV, Gajda M, Round A, Kong C, Lim M, Nakamura Y, Svergun DI, Ito K, Song H. Structural insights into eRF3 and stop codon recognition by eRF1. Genes Dev. 2009 May 01; 23(9):1106-18. PMID: 19417105.
    Citations: 64     Fields:    Translation:HumansAnimalsCells
  102. Kong CY, McMahon PM, Gazelle GS. Calibration of disease simulation model using an engineering approach. Value Health. 2009 Jun; 12(4):521-9. PMID: 19900254.
    Citations: 23     Fields:    Translation:Humans
  103. Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics. 2009; 27(7):533-45. PMID: 19663525.
    Citations: 50     Fields:    Translation:Humans
  104. McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS. Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer. 2008 Dec 15; 113(12):3440-9. PMID: 18988293.
    Citations: 18     Fields:    Translation:HumansPHPublic Health
  105. Hur C, Broughton DE, Kong CY, Ozanne EM, Richards EB, Truong T, Gazelle GS. Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci. 2009 Oct; 54(10):2207-14. PMID: 19057995.
    Citations: 1     Fields:    Translation:Humans
  106. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology. 2008 Jul; 248(1):278-87. PMID: 18458247.
    Citations: 37     Fields:    Translation:HumansPHPublic Health
  107. Yeh JM, Kuntz KM, Ezzati M, Hur C, Kong CY, Goldie SJ. Development of an empirically calibrated model of gastric cancer in two high-risk countries. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1179-87. PMID: 18483340.
    Citations: 14     Fields:    Translation:HumansCells
  108. Kong CY, Muthukumar M. Simulations of stochastic sensing of proteins. J Am Chem Soc. 2005 Dec 28; 127(51):18252-61. PMID: 16366579.
    Citations: 5     Fields:    
  109. Paaventhan P, Kong C, Joseph JS, Chung MC, Kolatkar PR. Structure of rhodocetin reveals noncovalently bound heterodimer interface. Protein Sci. 2005 Jan; 14(1):169-75. PMID: 15576563.
    Citations: 3     Fields:    Translation:AnimalsCells
  110. Kong C, Ito K, Walsh MA, Wada M, Liu Y, Kumar S, Barford D, Nakamura Y, Song H. Crystal structure and functional analysis of the eukaryotic class II release factor eRF3 from S. pombe. Mol Cell. 2004 Apr 23; 14(2):233-45. PMID: 15099522.
    Citations: 58     Fields:    Translation:AnimalsCells
  111. Kong CY, Muthukumar M. Modeling of polynucleotide translocation through protein pores and nanotubes. Electrophoresis. 2002 Aug; 23(16):2697-703. PMID: 12210174.
    Citations: 18     Fields:    
  112. J. McNamara, C.Y. Kong, and M. Muthukumar. Monte Carlo Studies of Adsorption of a Sequenced Polyelectrolyte to Patterned Surfaces. J. Chem. Phys. 2002; 117(11):5354-60.
  113. M. Ellis, C.Y. Kong and M. Muthukumar, . Polyelectrolyte Adsorption on Heterogeneously Charged Surfaces. J. Chem. Phys. 2000; 112(19):8723-9.
  114. C.Y. Kong and M. Muthukumar. Monte Carlo Study of Adsorption of a Polyelectrolyte onto Charged Surfaces. J. Chem. Phys., 1998; 109(4), 1522-7. 1998; 109(4):1522-7.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (314)
Explore
_
Co-Authors (62)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.